Unicycive Therapeutics (UNCY) EPS (Basic) (2020 - 2026)
Unicycive Therapeutics posted quarterly EPS (Basic) of -$0.54 for Q1 2026, down 1450.0% year-on-year from $0.04 in Q1 2025, and up 34.15% on a QoQ basis from -$0.82 in Q4 2025.
Unicycive Therapeutics (UNCY) has 7 years of EPS (Basic) data on file, last reported at -$0.54 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Basic) fell 1450.0% year-over-year to -$0.54; the trailing twelve-month figure through Mar 2026 stood at -$2.21 (up 2.21% YoY), and the FY2025 full-year result was -$1.67, up 70.44% from the prior year.
- EPS (Basic) for Q1 2026 stood at -$0.54, up from -$0.82 in the prior quarter.
- Across five years, EPS (Basic) topped out at $0.8 in Q2 2024 and bottomed at -$2.64 in Q4 2024.
- The 5-year median for EPS (Basic) is -$0.35 (2022), against an average of -$0.46.
- Peak annual rise in EPS (Basic) reached 375.86% in 2024, while the deepest fall reached 1550.0% in 2024.
- A 5-year view of EPS (Basic) shows it stood at -$0.35 in 2022, then jumped by 54.29% to -$0.16 in 2023, then slumped by 1550.0% to -$2.64 in 2024, then jumped by 68.94% to -$0.82 in 2025, then surged by 34.15% to -$0.54 in 2026.
- The last three EPS (Basic) figures came in at -$0.54 (Q1 2026), -$0.82 (Q4 2025), and -$0.33 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 3.06 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 0.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 0.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 4.06 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 0.00 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 6.99 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1.55 |
| 10 | Unicycive Therapeutics | 181.94 Mn | 127.36 Mn | - | -0.54 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.54 |
| Dec 31, 2025 | -0.82 |
| Sep 30, 2025 | -0.33 |
| Jun 30, 2025 | -0.52 |
| Mar 31, 2025 | 0.04 |
| Dec 31, 2024 | -2.64 |
| Sep 30, 2024 | -0.46 |
| Jun 30, 2024 | 0.80 |
| Mar 31, 2024 | -0.61 |
| Dec 31, 2023 | -0.16 |
| Sep 30, 2023 | -0.13 |
| Jun 30, 2023 | -0.29 |
| Mar 31, 2023 | -0.97 |
| Dec 31, 2022 | -0.35 |
| Sep 30, 2022 | -0.37 |
| Jun 30, 2022 | -0.24 |
| Mar 31, 2022 | -0.24 |
| Dec 31, 2021 | -0.17 |
| Sep 30, 2021 | -0.37 |
| Jun 30, 2021 | -0.13 |
| Mar 31, 2021 | -0.11 |
| Dec 31, 2020 | -0.11 |
| Sep 30, 2020 | -0.08 |
| Jun 30, 2020 | -0.04 |